Clinical trials
Completed Community-Acquired Pneumonia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
153 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 4 |
| 2003 | 1 |
| 2004 | 6 |
| 2005 | 3 |
| 2006 | 6 |
| 2007 | 8 |
| 2008 | 3 |
| 2009 | 9 |
| 2010 | 6 |
| 2011 | 8 |
| 2012 | 9 |
| 2013 | 8 |
| 2014 | 3 |
| 2015 | 8 |
| 2016 | 8 |
| 2017 | 7 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 10 |
| 2022 | 8 |
| 2023 | 9 |
| 2024 | 4 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 153 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 10 |
| Bayer | 5 |
| Assistance Publique - Hôpitaux de Paris | 4 |
| TaiGen Biotechnology Co., Ltd. | 4 |
| UMC Utrecht | 4 |
| Forest Laboratories | 3 |
| Abbott | 2 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 2 |
| Basilea Pharmaceutica | 2 |
| Biotest | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Community-Acquired Pneumonia | 153 |
| Pneumonia | 60 |
| Pneumonia, Bacterial | 14 |
| Healthcare-Associated Pneumonia | 10 |
| Sepsis | 6 |
| Bronchitis | 5 |
| Infections | 5 |
| Pulmonary Disease, Chronic Obstructive | 5 |
| Pneumococcal Infections | 4 |
| Respiratory Tract Infections | 4 |
Trials
Showing 1 to 25 of 153. Each trial links to its page on Pharma Observatory.
53 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.